company background image
28 logo

China National Accord Medicines SZSE:000028 Stock Report

Last Price

CN¥35.98

Market Cap

CN¥18.4b

7D

5.4%

1Y

-27.8%

Updated

25 Apr, 2024

Data

Company Financials +

China National Accord Medicines Corporation Ltd.

SZSE:000028 Stock Report

Market Cap: CN¥18.4b

28 Stock Overview

China National Accord Medicines Corporation Ltd.

28 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Rewards

Risk Analysis


China National Accord Medicines Corporation Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China National Accord Medicines
Historical stock prices
Current Share PriceCN¥35.98
52 Week HighCN¥52.55
52 Week LowCN¥26.06
Beta0.32
1 Month Change20.66%
3 Month Change19.73%
1 Year Change-27.75%
3 Year Change13.75%
5 Year Change-0.76%
Change since IPO1,374.24%

Recent News & Updates

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Recent updates

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Shareholder Returns

28CN HealthcareCN Market
7D5.4%-0.9%-0.4%
1Y-27.8%-33.5%-14.4%

Price Volatility

Is 28's price volatile compared to industry and market?
28 volatility
28 Average Weekly Movement5.3%
Healthcare Industry Average Movement6.8%
Market Average Movement8.8%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 000028's share price has been volatile over the past 3 months.

Volatility Over Time: 000028's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199339,449Zhaoxiong Linwww.szaccord.com.cn

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. it offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, other professional consulting, and self-management services; agent services; import and export of various commodities and technologies; and house leasing services.

China National Accord Medicines Corporation Ltd. Fundamentals Summary

How do China National Accord Medicines's earnings and revenue compare to its market cap?
28 fundamental statistics
Market capCN¥18.43b
Earnings (TTM)CN¥1.60b
Revenue (TTM)CN¥75.48b

12.5x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
28 income statement (TTM)
RevenueCN¥75.48b
Cost of RevenueCN¥66.47b
Gross ProfitCN¥9.01b
Other ExpensesCN¥7.41b
EarningsCN¥1.60b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)2.87
Gross Margin11.93%
Net Profit Margin2.12%
Debt/Equity Ratio13.9%

How did 28 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

24%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.